Pharmacogenomics and personalized diabetology

Pharmacogenomics refers to the study of how genes affect a person's response to drugs. This field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses tailored to a person's genetic makeup.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-04-03
DOI
https://doi.org/10.5281/zenodo.15132488
Primary Topic
Pharmacogenetics and Drug Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacogenomics and personalized diabetology

Zenodo (CERN European Organization for Nuclear Research)
Pharmacogenetics and Drug Metabolism
article

Pharmacogenomics and personalized diabetology

article en

Abstract

Pharmacogenomics refers to the study of how genes affect a person's response to drugs. This field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses tailored to a person's genetic makeup.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 42%
Pharmacogenetics and Drug Metabolism
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pharmacogenomics and personalized diabetology · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS